位置:首页 > 蛋白库 > NR3AB_DANRE
NR3AB_DANRE
ID   NR3AB_DANRE             Reviewed;         672 AA.
AC   A1XQY0;
DT   21-SEP-2011, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 1.
DT   03-AUG-2022, entry version 73.
DE   RecName: Full=Neurexin-3a-beta;
DE   AltName: Full=Neurexin IIIb-beta;
DE   Contains:
DE     RecName: Full=Neurexin-3a-beta, soluble form;
DE   Contains:
DE     RecName: Full=Neurexin-3a-beta, C-terminal fragment;
DE              Short=NRXN3-CTF;
DE   Flags: Precursor;
GN   Name=nrxn3a;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Danionidae; Danioninae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], DEVELOPMENTAL STAGE, AND ALTERNATIVE SPLICING.
RX   PubMed=17041151; DOI=10.1093/molbev/msl147;
RA   Rissone A., Monopoli M., Beltrame M., Bussolino F., Cotelli F., Arese M.;
RT   "Comparative genome analysis of the neurexin gene family in Danio rerio:
RT   insights into their functions and evolution.";
RL   Mol. Biol. Evol. 24:236-252(2007).
CC   -!- FUNCTION: Neuronal cell surface protein that may be involved in cell
CC       recognition and cell adhesion.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=3;
CC         Comment=A number of isoforms, alpha-type and beta-type are produced
CC         by alternative promoter usage. Beta-type isoforms differ from
CC         alpha-type isoforms in their N-terminus.;
CC       Name=1b;
CC         IsoId=A1XQY0-1; Sequence=Displayed;
CC       Name=1a;
CC         IsoId=A1XQX8-1; Sequence=External;
CC       Name=2a; Synonyms=Soluble form;
CC         IsoId=A1XQX8-2; Sequence=External;
CC   -!- DEVELOPMENTAL STAGE: After the very early developmental stages, the
CC       expression levels decrease and remain relatively constant until around
CC       24 h, with the onset of an increase of expression that continues till
CC       the larval stages. {ECO:0000269|PubMed:17041151}.
CC   -!- PTM: Proccessed by alpha-secretase leading to the formation of an
CC       extracellular soluble protein as well as a C-terminal membrane-embedded
CC       fragment (CTF). Proteolysis of these CTFs by gamma-secretase releases
CC       intracellular domains (ICDs) and extracellular peptides (By
CC       similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 1b]: Produced by alternative promoter usage.
CC   -!- SIMILARITY: Belongs to the neurexin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ641434; ABG25171.1; -; mRNA.
DR   AlphaFoldDB; A1XQY0; -.
DR   SMR; A1XQY0; -.
DR   ZFIN; ZDB-GENE-070206-9; nrxn3a.
DR   Proteomes; UP000000437; Genome assembly.
DR   Proteomes; UP000814640; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   CDD; cd00110; LamG; 1.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR003585; Neurexin-like.
DR   InterPro; IPR027789; Syndecan/Neurexin_dom.
DR   Pfam; PF02210; Laminin_G_2; 1.
DR   Pfam; PF01034; Syndecan; 1.
DR   SMART; SM00294; 4.1m; 1.
DR   SMART; SM00282; LamG; 1.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 1.
PE   2: Evidence at transcript level;
KW   Alternative promoter usage; Alternative splicing; Angiogenesis;
KW   Cell adhesion; Membrane; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..35
FT                   /evidence="ECO:0000255"
FT   CHAIN           36..672
FT                   /note="Neurexin-3a-beta"
FT                   /id="PRO_0000412550"
FT   CHAIN           36..535
FT                   /note="Neurexin-3a-beta, soluble form"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000412551"
FT   CHAIN           536..672
FT                   /note="Neurexin-3a-beta, C-terminal fragment"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000412552"
FT   TRANSMEM        598..618
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          89..289
FT                   /note="Laminin G-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   REGION          319..340
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          417..454
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          495..532
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          640..672
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        422..437
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        499..525
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        640..654
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        655..672
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   672 AA;  72745 MW;  783B6D47EB065C47 CRC64;
     MRPSRVAAPF RGGRQGLSPW MWSLTLGCIV GSVWSSSPGL DNSVVAAGPP GVATSYTHPE
     HPVHNPRHHA SPISIYRSPA FLRSGHAGTT YIFGKGGGLL SFNWPANERP STRTDRLTVG
     FSTSLKDGIL IRIDSAPGLG DYLMLHIEQG KIGVTFNIGT ADITVQESST AVNDGKYHVV
     RFTRNGGNAT LQVDNWAINE HFPSGNSDNE RIQMANKKIP FKYARPVEEW LQEKGRQLTI
     FNTQATITIG GSDRKRPFQG QLSGLYYNGL KVLNMAAQGN PNIKINGSVR LVGEVPAAGS
     ARTTALPPEM STTFIETTTT MSTTTTRKHR TPPTIQTTDD MVSSAECSSD DEDFAECEGH
     AGGLGGELVF PVIVKDPLEL PSVATRTPSI PFPPTLTIIE TTKESLSMAT EAGVPCLSDG
     GSDDCGDDDD DDDDDGLMIS GYGSGEAYDS NLPPTDDEDF YTTFSLVTDK TLSSSTFEGG
     YKAHAPKWGS KDFRPNKVFD SGRTTTASFS PKLSRSTTTS TPPKLPAGKM NHRELKPQPD
     IVLLPLPTSY EVDNTKMKSP LITSPMFRNV PTAIPTEPGI RRVPGASEVV RESSSTTGMV
     VGIVAAAALC ILILLYAMYK YRNRDEGSYQ VDETRNYITN SAQSNGAVMK DKQQSTKSGN
     KKQKNKDKEY YV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024